CAS 74103-06-3
:Ketorolaco
Descripción:
Ketorolaco es un fármaco antiinflamatorio no esteroideo (AINE) utilizado principalmente por sus propiedades analgésicas, especialmente en el manejo del dolor moderado a severo. Se caracteriza por su capacidad para inhibir la enzima ciclooxigenasa (COX), que desempeña un papel crucial en la síntesis de prostaglandinas, compuestos involucrados en la inflamación y la señalización del dolor. Ketorolaco se administra a menudo por vía oral, intramuscular o intravenosa, y es conocido por su rápido inicio de acción. La sustancia se utiliza típicamente en entornos postoperatorios o para el alivio del dolor agudo, pero su uso generalmente se limita al tratamiento a corto plazo debido a posibles efectos secundarios, incluyendo sangrado gastrointestinal, deterioro renal y riesgos cardiovasculares. Ketorolaco también es notable por su potencia relativamente alta en comparación con otros AINE, lo que lo hace efectivo en dosis más bajas. Como con todos los medicamentos, es esencial usar Ketorolaco bajo supervisión médica para mitigar riesgos y monitorear efectos adversos.
Fórmula:C15H13NO3
InChI:InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)
Clave InChI:InChIKey=OZWKMVRBQXNZKK-UHFFFAOYSA-N
SMILES:C(=O)(C=1N2C(C(C(O)=O)CC2)=CC1)C3=CC=CC=C3
Sinónimos:- 1H-pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-
- 5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
- 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
- Aagn 199584
- Acular LS
- Keromin
- Rs 37619
- Sprix
- Sukerin
- acide 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylique
- Ketorolac
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 10 productos.
Ketorolac Tromethamine
CAS:Fórmula:C15H13NO3·C4H11NO3Pureza:>98.0%(T)(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:376.41Ketorolac
CAS:Ketorolac (Acuvail) is an NSAID that blocks prostaglandin synthesis, related to heterocyclic acetic acids.Fórmula:C15H13NO3Pureza:99.68%Forma y color:White Crystalline Or White PowderPeso molecular:255.275-Benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid
CAS:<p>5-Benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid</p>Fórmula:C15H13NO3Pureza:95%Forma y color: light yellow powderPeso molecular:255.27g/molrac Ketorolac
CAS:Producto controlado<p>Applications Ketorolac is an analgesic; anti-inflammatory.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Etman, M., et al.: Pharm. Technol., 32, 58 (2008), Chelladurai, S., et al.: Chem. Pharm. Bull., 56, 1596 (2008), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),<br></p>Fórmula:C15H13NO3Forma y color:Off White SolidPeso molecular:255.275-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:255.2729949951172Ketorolac
CAS:<p>Ketorolac is a nonsteroidal anti-inflammatory drug that acts by inhibiting the synthesis of prostaglandins. It is used to control moderate to severe pain, and for reducing postoperative, postpartum and other types of pain. Ketorolac has been shown to be effective in a variety of clinical settings, including those involving hepatic impairment and congestive heart failure. The drug has minimal toxicity and can be used at high doses without adverse effects on the liver or kidney. In addition, ketorolac does not produce significant changes in pge2 levels in experimental models or human serum when administered orally.</p>Fórmula:C15H13NO3Pureza:Min. 98 Area-%Forma y color:PowderPeso molecular:255.27 g/mol5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic
CAS:<p>5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic (5BPC) is a drug that is used for the treatment of pain. It has been shown to be safe and effective in treating postoperative pain when given by intravenous infusion or as an oral tablet. 5BPC has minimal toxicity and is metabolized primarily by the liver with a half life of 2.6 hours. The drug has been found to have pharmacokinetic properties that allow it to be used safely in patients with hepatic impairment and in those recovering from abdominal surgery. 5BPC is a prodrug that undergoes biotransformation by esterases into its active form, pyrrolizidine alkaloid (PA). PA acts as a nonsteroidal anti-inflammatory agent and inhibits prostaglandin synthesis, which leads to analgesia. This drug also has minimal drug interactions because</p>Fórmula:C15H13O3NPureza:Min. 95%Peso molecular:255.27 g/mol







